Activation of voltage-gated calcium channels in the cell membrane leads to a cascade of intracellular events including: synaptic transmitter release, secretion, release of calcium from intracellular pools and activation of other ion channels. One im-portant mechanism regulating ion channel function is phosphorylation by Ca*+/phospholipid-dependent protein kinase C (PKC) (Chang et al., 1991) . Much of the published data concerning the effects of PKC on neuronal calcium channel function has been obtained using activators of endogenous PKC, such as diacylglycerol or phorbol esters (Swartz, 1993; Yang and Tsien, 1993) . The effects of phorbol esters on voltage-activated calcium channel function are somewhat controversial, with both decreased and increased Ca*+ currents reported (Rane and Dunlap, 1986; Lacerda et al., 1988; Gross and Macdonald, 1989; Madison, 1989; Rane et al., 1989; Boland et al., 1991; O'Dell and Alger, 1991; Swartz, 1993; Swartz et al., 1993; Yang and Tsien, 1993) . Several possible explanations for this discrepancy may exist. Phorbol esters are carcinogenic compounds that, in addition to activating endogenous PKC, may also directly inhibit the calcium channel at high concentrations (Hockberger et al., 1989; Doerner et al., 1990) . Intrinsic differences among various phorbol esters in their specificity of action on PKC have been described (Liu et al., 1993) . Increased calcium currents with acute application of PKC and decreased currents with prolonged contact has been reported (Mathies et al., 1987; Ewald et al., 1988) , suggesting that tachyphylaxis occurs with prolonged exposure to PKC activators. Other potential variables include variations between cell types and species in the endogenous baseline PKC levels, the types of PKC isoforms present (Tanaka and Saito, 1992) , or the mechanism(s) of PKC action on calcium channels (Alkon and Rasmussen, 1988 ). An attenuating effect of phorbol esters on PKC levels has been reported (Rodriguez-Pena and Rozengurt, 1984; Wolf et al., 1984) . Finally, recruitment of covert or previously inactive calcium channels by PKC has been described in Aplysia neurons (Strong et al., 1987) .
Because the effects of indirect activation of PKC are unclear, we decided to administer a constitutively active form of PKC directly into the cell through the recording pipette, and thus to determine the direct effect of PKC on whole cell calcium currents in acutely dissociated dorsal root ganglion (DRG) neurons.
Materials and Methods
All animal, experimentation was conducted in accordance with the National Institutes of Health Guidelines for the care and use of laboratory animals (NIH Publication 85-23, revised 1985) . Preparation of acutely dissociated neurons. DRG neurons were prepared from 14-21 d old Sprague-Dawley rats of both sexes using a technique similar to that described previously (Gross et al., 1990a Constitutively active PKC (PKM) was isolated and purified from bovine brain as previously described (Woodgett and Hunter, 1987; Browning et al., 1990) . Removal of Ca*+/phospholipid dependency of PKC was achieved by trypsin treatment (Huang and Huang, 1986) . After trypsin treatment, PKM was repurified by soybean trypsin inhibitor affinity column chromatography, concentrated, and dialyzed against a buffer with the following composition: TEA 2 mM. EGTA 5 mM. MgCl, 6 mM. KC1 140 mM. HEPES 10 mM, CaCl, 1 'mM, and titrated ;o pH 7.5 with KOH. Following sequencing, the subunit was synthesized, dissolved in aqueous buffer to a concentration of 5 pglml and stored as 2-5 ml aliquots at -70°C.
PKC inhibitory peptide (PKC-I) with a sequence identical to amino acids 19-31 of protein kinase C was synthesized, dissolved in aqueous buffer to a concentration of 4 mM and stored at -70°C.
Preparation
of solutions.
PKM, PKC inhibitor peptide, and vehicle were stored at -70°C as aliquots of the stock solutions described above. Just before use, working solutions of PKM, PKM+PKC-I, PKC-I alone, and vehicle (control) were prepared. The stock PKM was diluted with internal recording solution (see below) to 2040 nM and vehicle was similarly diluted to serve as a control. Stock PKC-I was diluted with vehicle to a concentration of 4 FM. To obtain solution containing both PKM+PKC-I, the stock PKC-I was diluted with the working solution of PKM to a concentration of 4 PM PKC-I, and incubated at 37°C for 15 min to inactivate PKM. When using solutions containing PKM, PKC-I or vehicle, the recording electrode tip was tilled with plain internal recording solution, then back-tilled with the peptide-containing solution. w-conotoxin GVIA (Sigma) was dissolved in filtered distilled water (1 mM stock) and 10 ml aliquots were lyophilized and stored at -20°C. Just before the experiment w-conotoxin was reconstituted in external recording solution (see below) to a concentration of l-10 PM. On the day of the experiment nifedipine (Sigma) was dissolved in dimethylsulfoxide (DMSO) to IO mu, then diluted with external recording solution to l-10 PM and kept covered with aluminum foil to exclude light. All solutions, except the external recording solution, were kept on ice throughout the experiment.
Whole-cell patch-clump recording techniques.
Voltage-clamp recordings were made using the whole-cell variant of the patch-clamp technique (Hamill et al., 198 I) with glass recording patch pipettes (Fisher Microhematocrit tubes, Fisher Scientific, Pittsburgh, PA), electrode tip resistances of 1-2 MQ and seal resistance greater than 1 GR The external solution contained 5 mM CaCl,, 67 mM choline Cl, 100 mM tetraethylammonium chloride, 5.6 mM glucose, 5.3 mM KCL, IO mM Hepes, and 0.8 mM Mg2+Cl, (pH 7.337.4, (320) (321) (322) (323) (324) (325) (326) (327) (328) (329) (330) . Recording electrodes were filled with recording solution consisting of 140 mM cesium Cl, 10 mM Hepes, 10 mM EGTA, 5 mM Mg2+ATP and 0.1 mM Li+GTP (all reagents from Sigma). The pH was adjusted to 7.2-7.3 with 1 M CsOH after addition of ATP and GTP, and the final osmolality (280-290) was lo-15% below that of the external recording solution. Experiments were performed with vehicle diluted in internal recording solution (control) or solutions containing PKM, PKM+PKC-I, or PKC-I alone diluted in recording solution (treated) which were "dialyzed" into the cell following patch rupture. In 10 cells, significant amounts of recording solution containing phenol red dye could be seen to enter 10 cells within l-3 min of patch rupture, indicating that under the recording conditions used, significant dialysis of electrode contents would likely have occurred within the first 3 min of recording.
Cells were stimulated with voltage steps generated by the program CLAMPEX @CLAMP, Axon Instruments, Foster City, CA) and detected using an Axopatch 1 B patch-clamp amplifier (Axon Instruments). Initial input resistances were 500 Ma to 1.5 GR and series resistance l-4 M0. Currents were filtered with a Bessel filter at 10 kHz (-3 dB), stored, and analysed with the program CLAMPAN (Axon Instruments). Nifedipine and o-conotoxin GVIA were applied to the cell using pressure injection (0.5 kPa) from blunt-tipped (IO-40 km opening) glass micropipettes positioned approximately 50 p,m from the cell. The pipettes were lowered into the bath immediately prior to a 2-5 set application of drug, then after a 2 set pause following drug application, currents were evoked by depolarization. After lo-30 set, a second application was performed, currents evoked, and the pipette removed from the bath. Application of diluent alone had no effect on the calcium current amplitude.
Analysis of current components.
At least three calcium current components were present in nodose and DRG neurons (Nowyky et al., 1985; Fox et al., 1987) . The T-current was isolated by depolarizing the cell from holding potentials (V,,) of -80 or -90 mV to command potentials (V,) of -60 to -30 mV. Depolarizations more positive than -30 mV evoked higher threshold current components that activated and inactivated more slowly (N, L, non-N,L). Currents were evoked by depolarization to V, = 0 -+ IO mV at 1 min intervals after patch rupture, with the cell alternately held at a V,, of -80 mV and -40 mV. The slowly inactivating current evoked by depolarization to a V, = 0 to + 10 mV from V,, = -40 mV was used as an estimate of the L+non-N,L current component, and the additional, more rapidly inactivating current component evoked from V,, = -80 mV as an estimate of the N current component. Pharmacologic antagonists were also used to determine the relative proportion of current attributable to N-, L-, and non-N,L-type calcium currents, by measuring the percentage of current abolished by the N-type antagonist o-conotoxin GVIA alone, and with the addition of the L-type antagonist nifedipine. In the presence of both antagonists, the mean residual (non-N,L) current was small, with an amplitude -25% of the current amplitude prior to the administration of antagonists. Calibration voltage pulses (Z5 mV) at V,r = -80 mV were obtained on representative cells immediately after patch rupture to normalize the currents for cell capacitance and check for bias in the cell size between control and PKM-treated cells.
Leak current was estimated as the inverse of the current generated by hyperpolarizing commands of equal value to those used to depolarize the cell. These were digitally subtracted from the appropriate inward current to obtain the leak-subtracted calcium current.
Current-voltage (IV) curves were constructed in the following manner. As soon as possible after patch rupture, each cell was depolarized in 10 mV steps increasing from -30 mV to + 160 mV from a holding potential of -80 mV. This produced command potentials (V,) of -I 10 to +80 mV. Using the CLAMPAN program with the autopeak function set to a three point average, the peak inward current was determined for each current trace, and plotted as a function of V,. The baseline was determined by a least-squares fit of the line connecting the points from -110 mV to -60 mV, and this line was subtracted from the data points at each voltage step. The baseline-subtracted curves were averaged to produce mean + SEM values at each voltage step for control and PKMtreated cells.
Significance was determined using the two-tailed Student t test and analysis of variance (ANOVA) functions of the InStat program (GRAPH-PAD), and defined as a p value < 0.05.
Results

PKM enhanced calcium currents in rat dorsal root ganglion neurons
Whole cell voltage-activated calcium currents were elicited in isolated, dissociated DRGs by depolarization to + 10 mV from holding potentials (V,,) of -80 mV alternating with -40 mV at 1 min intervals. Currents corresponding to both low threshold voltage-activated (T-type) and high threshold voltage-activated (N-, L-, and non-N,L) (Nowycky et al., 1985; Mintz et al., 1992) were observed. As the T-type currents were present in <IO% of neurons, analysis was confined to the high threshold voltageactivated currents. In Figure 1 , the mean + SEM of the peak inward currents elicited from V, = -80 mV (A), .and V,, = -40 mV (B) for 39 control cells and 39 cells treated with PKM are plotted against time from patch rupture. Representative high threshold voltage-activated calcium currents recorded in DRGs stimulated by the protocol described above are shown in Figure  1C . The left-hand tracing was recorded in a neuron dialyzed with buffer-containing control recording solution, the right-hand tracing from a DRG dialyzed with recording solution containing 20 nM PKM. In both control and PKM-treated neurons, currents evoked from more negative holding potentials (V, = -80 mV; solid squares) had larger peak amplitudes than currents evoked from more positive holding potentials (V,, = -40 mV; open squares).
As can be seen in the plots of I,, versus time (Fig. lA,B) , the The rate of calcium current rundown was sign$cantly increased by PKC-I Rundown of current with time was seen in both control and PKM-treated cells (Fig. I) , and appeared to be more rapid in cells treated with PKM compared to control cells. In individual experiments, however, peak currents occured at different times from patch rupture, and thus the rundown portions of the current vs time curves did not coincide. In addition we noted that cells with larger currents (whether control or PKM-treated) tended to run down more quickly than those with smaller currents. To remove these potential sources of bias we normalized the rundown portion of the curve for each cell as a percentage of the peak current attained by that cell. For each experiment, currents evoked by depolarizations in the rundown period following the maximum observed current were normalized to the maximum current and plotted versus time for both V,< = -80 mV ( Fig.  2A ) and -40 mV (Fig. 2B) .
The PKM-treated cells demonstrated a small, nonsignificant trend towards less rundown of normalized current with time compared to control cells. Cells treated with PKM+PKC-I had significantly increased rundown compared to controls and PKMtreated cells. In neurons treated with PKC-I alone (n = 4), the rundown rate was not significantly different from that seen in the presence of both PKM+PKC-I.
These results, that is, little incremental effect of additional PKM, and a significant effect of PKC-I, both alone and with PKM, suggested a relatively high level of endogenous PKC activity may have been present in these cells.
PKM did not change the peak current-voltage (IV) relationship
In frog sympathetic neurons, activation of PKC by 12,13-phorbol dibutyrate (PDBu) caused a slight shift in the voltage-de- Time (min) Figure 2 . Addition of PKC-I significantly increased the rate of current rundown. Rates of current rundown in control and PKM-treated cells were compared by dividing inward currents (-I,,,) at each time point by the maximum inward current (-&Fax) attained during the experiment. The rundown period was defined as the period following the maximum Ic,, for each cell. There was no sigmhcant difference in the rate of rundown of calcium currents in control versus PKM-treated neurons at either V,, = -80 mV (A) or V,, = -40 mV (B). Addition of PKC-I caused a significant increase in rundown compared to control or PKM-treated cells (# p < 0.001; ***, p < 0.005; ** p < 0.01; *, p < 0.05, ANOVA). Each value is the mean i SEM of (n) cells.
pendence of the IV relationship to more negative potentials (Yang and Tsien, 1993) . current was significantly (p < 0.05) larger in PKM-treated neurons; however, there was no significant shift in the voltage dependence of the peak current, which occurred at + IO mV in both control and PKM-treated cells. Thus the increase in whole cell high-threshold calcium currents observed with PKM treatment in this preparation cannot be explained by a shift in the voltage dependence of the IV relationship in PKM-treated cells.
PKM enhanced N-and L-type calcium currents
We proceeded to test the effect of N and L-type calcium channel blockers on the enhancement of I,, evoked from -80 mV observed in PKM-treated cells. In Figure 4 , the results of a representative experiment in a DRG neuron in which PKM was present in the recording electrode (A) and the corresponding current traces (B) obtained at the time points (1) predrug, (2) postw-conotoxin GVIA (o-CgTX) 10 PM, and (3) post-w-CgTX 10 PM + nifedipine 3 PM are shown.
In the experiment shown in Figure 4A , a DRG neuron dialyzed with PKM was held at -80 mV and currents were elicited by depolarization to + 10 mV. Two applications of o-CgTX were given 1 min apart at the times marked by the arrows. There was little incremental effect of the second application, indicating that the block by both anatgonists was essentially complete. No recovery from the effect of w-CgTX was observed; however following application of 3 FM nifedipine, partial recovery of peak inward current amplitude was noted. This was consistent with the action of nifedipine (a reversible L-channel antagonist). Little or no recovery of current amplitude was observed in the presence of higher concentrations of nifedipine (10 FM). The values for the average peak I,, in the presence of (1) no drug (predrug), (2) , an estimate of the portion of current attributable to N in both control (2.0 nA) and PKM-treated cells (2.9 nA) was determined. Similarly, an estimate of N + L was calculated by subtracting the current remaining in the presence of both o-CgTX + nifedipine from the pre-drug current for control (2.8 nA) and PKM-treated cells (3.7 nA). Finally an estimate of the portion of current attributable to L was calculated by subtracting the value for N calculated above from the value for N + L (control: 0.8 nA, PKM-treated: 0.8 nA). The small residual current remaining in the presence of w-CgTX and nifedipine was termed the non-N,L component (control: 0.9 ? 0.1 nA, PKM-treated:
1.8 + 0.4 nA). The three components (N, L, and non-N,L) were converted to percentages of the total predrug current (no drug) ( Table 1) .
Using the ANOVA test, there was no significant difference between control and PKM-treated cells in the percentage of current attributable to the N, L, and non-N,L components, implying that the increase in calcium currents observed with PKM treatment affected all three current groups (N, L, and non-N,L).
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Discussion Figure 4 . PKM enhanced N, L, and non-N,L current components. In A, inward currents elicited in a PKM-treated neuron by depolarization from V,z = ~80 mV to V, = + 10 mV are plotted versus time from patch rupture. After the maximum calcium current was observed, two applications of the N-type channel antagonist o-conotoxin GVIA (wCgTX, 10 mM) were administered from a pipette placed close to the cell. Following each application, currents were elicited. After the second application the drug pipette was withdrawn from the bath. The predrug current amplitude (I) was decreased by the first application of o-CgTX (2) and the second application had little additional effect. Currents were elicited for 2 min, then 3 mM nifedipine was applied in a similar manner from a separate pipette. Nifedipine caused a further decrease (3) in current amplitude, following which partial recovery was observed. In B representative current tracings from a control and a PKM-treated neuron corresponding to the experimental time points I, 2, and 3 above are shown. C summarizes the experimental results. When compared with control cells, cells dialyzed with PKM had significantly increased peak currents prior to drug administration (I, a = I6 (control), 22 (PKM); *:b*, p.< O.OOS), following w-CgTX 10 mM (2, IZ = 16 (control), 22 (PKM); *, p < 0.05) and following nifedipine IO mM (3, n = 15 (control), 16 (PKM); **, p < 0.01). Each bar is the mean 5 SEM.
0.005). In the presence of the N-type channel antagonist (oCgTX), the average peak current was reduced by 54% in control cells (1.7 -C 0.2 nA) and by 53% in PKM-treated cells (2.6 -C 0.5 nA). Cells treated with PKM still demonstrated a significantly 0, < 0.05) increased peak I,, compared to controls. In the presence of both w-CgTX and nifedipine, peak I,, decreased by 76% in control cells (0.9 -C 0.1 nA), and by 67% in PKMtreated cells (1.8 t 0.4 nA), with a significantly higher 0, < 0.01) current observed in PKM-treated cells compared to con- 
PKM enhunced whole cell calcium currents in rut DRGs
We demonstrated that a constitutively active form of PKC (PKM), when dialyzed into the cell via the recording pipette, increased peak high voltage-activated calcium currents in acutely dissociated rat primary afferent ganglion neurons. These experiments suggested that the net action of PKC on voltage-dependent calcium channels in this preparation was enhancement.
Our data obtained in the presence of calcium channel blockers indicate that PKM appeared to increase both N-and L-type currents (Braha et al., 1993; Yang and Tsien, 1993) and in addition, affected a residual (non-N,L) calcium current that was relatively slowly inactivating.
Several high voltage-activated currents (P, Q, and others) with activation and inactivation ranges that overlap those of the N-and L-type currents have been described recently (Lhnas et al., 1989; Mintz et al., 1992; Elhnor et al., 1993; Randall et al., 1993) and the non-N,L component of the calcium current observed in this study is likely comprised of one or more of these additional high voltage-activated calcium currents. Use of specific antagonists that block these additional currents (Aga TVs; P-type, w-conotoxin MVIIC; Q-type), may identify other calcium currents enhanced by PKM administration.
There appeared to be a high endogenous level of PKC activity in this preparation. PKM treatment did not alter the rate of current rundown compared to control neurons. Dialysis with either PKMfPKC-I-containing solution, or recording solution containing only PKC-I significantly increased the current rundown rate compared to control and PKM-treated neurons. The concentra-tion of PKC-I administered was greatly in excess of the PKM concentration. Thus, additional PKC activity in the form of PKM did not substantially affect rundown, however inhibition of exogenous PKM and endogenous PKC by a large excess of PKC-I resulted in a significant increase in rundown. Whether the high endogenous PKC activity inferred from these experiments was a result of the dissociation process, or a normal feature of DRG neurons is not known. Progressively increasing PKC activity over several days has been qbserved in neuronal cultures (Burgess et al., 1986) and in acutely dissociated superior cervical ganglion neurons after prior removal of central inputs in viva (Roivainen, 1991) , suggesting that increased PKC activation may be a physiological response to denervation and/or dissociation. Increased PKC activity has been implicated as a pathogenic factor in some models of neuronal death (Manev et al., 1989; Hara et al., 1990; Mattson, 1991; Candeo et al., 1992) , implying that elevated PKC activity could be pathologic in these systems.
Experiments using phorbol esters to activate endogenous PKC have demonstrated some variability in the reported effects. Phorbol esters increase peak calcium currents in sensory neurons from rat and other species (Swartz, 1993; Swartz et al., 1993; Yang and Tsien, 1993) . However, phorbol esters have also been reported to decrease calcium currents (Rane and Dunlap, 1986; Gross and Macdonald, 1989; Rane et al., 1989; Boland et al., 1991) . There are several possible explanations for this discrepancy. Phorbol esters activate PKC by binding to the cytosolic (inactive) form of PKC, and therefore, variations in endogenous cytosoiic PKC levels could influence the magnitude of the effect of phorbol esters on calcium currents. Secondly, the activation process for PKC requires translocation of the activated molecule to the plasma membrane (or other site of action), and differences in translocation of isoforms of PKC have been described (Kruger et al., 1991) . Thus, variations in the effects of indirect activators of PKC might be due to preexisting variations in endogenous PKC content, activation, or translocation, as well as differences in the action of PKC at its target. Attenuation of PKC levels in response to phorbol ester administration has been reported (Rodriguez-Pena and Rozengurt, 1984; Wolf et al., 1984) . In addition, there is ividence that phorbol esters may directly inhibit calcium channel function (Hockberger et al., 1989; Doerner et al., 1990) , and thus their actions on the calcium channel may not be mediated solely by alterations in PKC activity.
Pututive mechunisms qf'action of PKM PKM may be modulating calcium channel activity by phosphorylation of one or more channel subunits. There are several consensus phosphorylation sites for PKC on the cloned otl (Dube1 et al., 1992) and p (Hullin et al., 1992) subunits of the L-type calcium channel, and PKC can phosphorylate these sites in vitro (Jahn et al., 1988; Ahlijanian et al., 1991) . The PKM preparation used in this study has been shown to phosphorylate a known consensus site on the a subunit of the y-amminobutyric acid A receptor (GABA,) (Browning et al., 1990) . Another possibility is that PKM may modulate calcium channel function indirectly by phosphorylation of other structures associated with calcium channels, such as G proteins. Inhibitory G proteins have been implicated as a second messenger system involved in the modulation of calcium currents by various receptor agonists (Gross et al., 1990; Swartz, 1993) ; however, using GTP analogs, Yang and Tsien (1993) did not find evidence for G protein involvement in the effects of the phorbol ester PDBu on frog sympathetic ganglion calcium currents.
The increase in calcium current seen in the PKM-treated cells could be explained by an increase in either channel number, conductance or open time. It is possible that the observed effect of acute PKM treatment on calcium current was due to an increased total number of calcium channels. This alteration would have to occur within the first few minutes of application, since currents in cells treated with PKM were higher than controls within the first minute of administration.
This could occur as a result of addition of new channels into the membrane, or by recruitment of previously inactive calcium channels, as has been described in Aplysia (DeRiemer et al., 198.5; Strong et al., 1987) . Our results suggest that such alterations in channel number would have to involve N, L, and additional high-threshold voltage-activated calcium channels. Although the present experiments cannot determine whether alterations in the underlying channel properties were responsible for the increased whole-cell calcium current caused by PKM, we can speculate that increased calcium channel conductance, open time and/or opening frequency might play a part. Our current-voltage curves indicate that whole cell conductance was likely increased, without a significant shift in the voltage range of activation. Indirect activation of PKC by phorbol esters has been shown to increase N and L channel opening probability (Yang and Tsien, 1993) . Based on single channel data, several investigators have postulated that calcium channels may reside in different modes that are more or less excitable (Boland and Bean, 1993; Delcour et al., 1993) , and that the action of PKC is to switch the cell to a more easily excited mode (Yang and Tsien, 1993) . Whether differences in underlying G protein activity determine the modal status is presently a subject of debate (Boland and Bean, 1993) .
In addition to the actions of PKC, the phosphorylation status of calcium channels may be independently modulated by other kinases, such as CAMP-dependent protein kinase (PKA, Gross et al., 1990b; Ahlijanian et al., 1991; Diverse-Pierluissi and Dunlap, 1993) , and by endogenous phosphatases. Inhibition of endogenous phosphatases would prolong the phosphorylated state, and possibly increase calcium currents.
In summary we have observed that constitutively active PKC (PKM) increased voltage-activitated calcium currents in rat dorsal root ganglion neurons. This effect was in contrast to the reported effects of some phorbol esters to reduce calcium currents, and implies that some of the effects of phorbol esters, notably calcium current inhibition, may involve mechanisms other than, or in addition to activation of endogenous PKC. The mechanism by which PKM enhances calcium currents in this preparation is not yet clear; however a shift in the voltage dependence of the current-voltage relationship does not appear to be involved.
